Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 Labeling index is a predictor for recurrence of adrenocortical carcinomas

被引:107
|
作者
Morimoto, Ryo [1 ]
Satoh, Fumitoshi [1 ]
Murakami, Osamu [1 ]
Suzuki, Takashi [2 ]
Abe, Takaaki [1 ]
Tanemoto, Masayuki [1 ]
Abe, Mlchiaki [1 ]
Uruno, Akira [1 ]
Ishidoya, Shigeto [3 ]
Arai, Yoichi [3 ]
Takahashi, Kazuhiro [4 ]
Sasano, Hironobu [5 ]
Ito, Sadayoshi [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Med, Div Nephrol Endocrinol & Vasc Med,Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Sch Hlth Sci, Dept Pathol, Sendai, Miyagi 9808574, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi 9808574, Japan
[4] Tohoku Univ, Sch Hlth Sci, Dept Analyt Med Technol, Sendai, Miyagi 9808574, Japan
[5] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808574, Japan
关键词
adrenocortical carcinoma; prognosis; Ki67;
D O I
10.1507/endocrj.K07-079
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adrenocortical carcinoma (ACC) is a rare, highly malignant tumor. The aim of the present study is to evaluate the prognostic relevance of a proliferation marker Ki67/MIB1 by immunohistochemistry in 17 cases who underwent resections of the primary tumors and diagnosed to have ACC at Tohoku University Hospital based on the criteria of Weiss during the period from 1976 to 2005. The follow-up periods ranged from 221 days to 10659 days (about 29 years) with the median of 1895 days. The median age at diagnosis was 46 years old, and the mean size of the primary tumors was 7.1 cm with the minimal of 3.5 cm. Ki67/MIB1 labeling index (Ki67/MIB1LI) ranged from 1% to 26%. Kaplan-Meier analysis revealed that patients with Ki67/MIB1LI of 7% or more were associated with significantly shortened disease-free survival (P = 0.0037). The evaluation with Weiss criteria revealed that the median score of Weiss criteria was five, and 13 patients (76.5%) presented positive findings in the criteria of mitotic rate. The survival analysis with Weiss score showed that patients with the scores of 6 or more had both significantly shortened disease-free survival (P = 0.0001) and overall survival (P = 0.0063). The present study has suggested that Ki67/MIB1LI, as well as Weiss score, is a useful predictor for tumor recurrence after resection of the primary tumors in patients with ACC.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 50 条
  • [21] Proliferation Marker Ki67 as a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal Melanoma
    Tang, Lirui
    Wei, Xiaoting
    Li, Caili
    Dai, Jie
    Bai, Xue
    Mao, Lili
    Chi, Zhihong
    Cui, Chuanliang
    Lian, Bin
    Tang, Bixia
    Du, Yu
    Wang, Xuan
    Lai, Yumei
    Sheng, Xinan
    Yan, Xieqiao
    Li, Siming
    Zhou, Li
    Kong, Yan
    Li, Zhongwu
    Si, Lu
    Guo, Jun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma
    Belderbos, Robert A.
    Maat, Alexander P. W. M.
    Baart, Sara J.
    Madsen, Eva V. E.
    Bogers, Ad J. J. C.
    Cornelissen, Robin
    Aerts, Joachim G. J. V.
    Mahtab, Edris A. F.
    von der Thuesen, Jan H.
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (04):
  • [23] The significance of Ki-67/MIB-1 labeling index in human meningiomas: A literature study
    Abry, Ellen
    Thomassen, Ingrid O.
    Salvesen, Oyvind O.
    Torp, Sverre H.
    PATHOLOGY RESEARCH AND PRACTICE, 2010, 206 (12) : 810 - 815
  • [24] Ki-67 (clone MIB-1) proliferation index in recurrent glial neoplasms: No prognostic significance
    Litofsky, NS
    Mix, TCH
    Baker, SP
    Recht, LD
    Smith, TW
    SURGICAL NEUROLOGY, 1998, 50 (06): : 579 - 585
  • [25] Alterations in Ki67 Labeling Following Treatment of Poorly Differentiated Neuroendocrine Carcinomas A Potential Diagnostic Pitfall
    Vyas, Monika
    Tang, Laura H.
    Rekhtman, Natasha
    Klimstra, David S.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (01) : 25 - 34
  • [26] Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease - An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies
    Abele, MC
    Valente, G
    Kerim, S
    Navone, R
    Onesti, P
    Chiusa, L
    Resegotti, L
    Palestro, G
    HAEMATOLOGICA, 1997, 82 (03) : 281 - 285
  • [27] MIB-1 labeling index, Ki-67, is an indicator of invasive intraductal papillary mucinous neoplasm
    Shimura, Tatsuo
    Kofunato, Yasuhide
    Okada, Ryo
    Yashima, Rei
    Okada, Koji
    Araki, Kenichiro
    Hosouchi, Yasuo
    Kuwano, Hiroyuki
    Takenoshita, Seiichi
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (02) : 317 - 322
  • [28] KI67 INDEX AND S-PHASE FRACTION IN HUMAN BREAST CARCINOMAS - COMPARISON AND CORRELATIONS WITH PROGNOSTIC FACTORS
    VIELH, P
    CHEVILLARD, S
    MOSSERI, V
    DONATINI, B
    MAGDELENAT, H
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 94 (06) : 681 - 686
  • [29] Determination of Ki-67 labeling index in pituitary adenomas using MIB-1 monoclonal antibody
    Lath, R
    Chacko, G
    Chandy, MJ
    NEUROLOGY INDIA, 2001, 49 (02) : 144 - 147
  • [30] Impact of Primary Antibody Clone, Format, and Stainer Platform on Ki67 Proliferation Indices in Breast Carcinomas
    Roge, Rasmus
    Nielsen, Soren
    Riber-Hansen, Rikke
    Vyberg, Mogens
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (10) : 732 - 739